Skip navigation

Calls to Action


A large clinical trial will test the safety and effectiveness of oxytocin nasal spray to improve sociability and communication in children and teens with autism. The federally funded clinical trial follows the promising results of a pilot study funded by Autism Speaks.

April 25, 2012

A compound that inhibits the brain chemical glutamate reduced repetitive behaviors and partially improved sociability in mouse models of autism. Though preliminary, the findings represent an important advance in autism research because they are the first to show consistent benefits from a pharmaceutical agent across two core symptoms.

December 23, 2011

WASHINGTON, DC (December 23, 2011) -- President Obama today signed into law an omnibus budget bill that includes an estimated $230 million in new federal funding for autism research and services, the first of three annual appropriations authorized under the Combating Autism Reauthorization Act.

September 12, 2007

Researchers at the National Institutes of Health, the Centers for Disease Control and Prevention, the Cincinnati Children's Hospital and the University Of Cincinnati College Of Medicine reported higher levels of growth-related hormones in boys with autism spectrum disorders as compared to typically developing boys. Researchers examined height, weight, levels of growth-related hormones and head circumference in 71 boys with autism or autism spectrum disorders and in 59 boys who did not have autism.

Autism Speaks, Science, NIH Discover Correlation between Growth Hormone Levels and Autism
September 02, 2008

The NIH has issued a funding opportunity announcement (FOA) request for grant applications entitled Research to Advance Vaccine Safety, designed to support research that will contribute to the overall understanding of vaccine safety.

Autism Speaks, Science, Latest Research